|
The National Institutes of Health (NIH) and the Food and Drug Administration (FDA) are pleased to announce the continuation of the Center for Coordination of Analysis, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science and renewed commitment to the Tobacco Centers of Regulatory Science (TCORS) program.
About CASEL
CASEL 2.0 will be administered through a cooperative agreement under award number 2-U54-DA046060-06, co-led by Jeanne Rosenthal (Westat) and Robin Mermelstein (University of Illinois at Chicago).
CASEL will facilitate synthesis, coordination, and communication of research and career enhancement within the scientific research programs funded by the FDA Center for Tobacco Products (CTP). Through leadership, coordination, and facilitation of communication and collaborative efforts among tobacco regulatory science investigators, CASEL can accelerate the identification, integration, and advancement of research findings relevant to the Family Smoking Prevention and Tobacco Control Act.
|
Introducing the CASEL Opportunity Fund
New to CASEL 2.0 is an Opportunity Fund (OF) that will support time-sensitive, rapid response projects to which extramural investigators may apply. The OF will be made available each year to support projects that address the high priority, time-sensitive research needs of the FDA CTP.
|
About the TCORS
NIH and the FDA have awarded a third cohort (TCORS 3.0) of centers to seven institutions.
The TCORS are a long-standing component of the Tobacco Regulatory Science Program. Made up of scientists with a broad range of expertise (e.g., epidemiology, economics, toxicology, addiction, and marketing), they generate critical research that informs the FDA’s regulation of tobacco products.
The TCORS 3.0 program continues to provide data on the following scientific domains related to the FDA’s regulatory authority for tobacco products:
- Understanding tobacco product composition and design
- Approaches that test the toxicity of non-cigarette tobacco smoke, aerosol, or specific constituents
- Effects of tobacco product characteristics on addiction and abuse liability
- Short- and long-term health effects of tobacco products
- Understanding knowledge, attitudes, and behaviors related to tobacco product use
- Understanding how to effectively communicate the health effects of tobacco products
- Influences of tobacco marketing
- Understanding the impact of potential or actual FDA regulatory actions
|
